Safety of peginterferon alfa-2a (40KD) treatment in patients with chronic hepatitis B infection: An observational, multicenter, open label, non-interventional study in Turkish patients

Nurdan TÖZÜN; Orhan Sezgin; Murat GÜLŞEN; Sabite KACAR; Necati YENİCE; Şerif YILMAZ; Saadettin HÜLAGÜ; Bülent KANTARÇEKEN; Fahri YAKARYILMAZ; Alper YURCİ; Kemal Mustafa SEREZ; Halil BAHÇECİOĞLU; Sait Bağcı

doi:10.4318/tjg.2012.0410

Original Article

Vol. 23 No. 5 (2012): Turkish Journal of Gastroenterology

DOI: https://doi.org/10.4318/tjg.2012.0410

Full Text PDF

Keywords:

Peginterferon alfa-2a, HBV infection, safety, patient compliance, tolerability, real-life practice

How to Cite

TÖZÜN, N., Sezgin, O., GÜLŞEN, M., KACAR, S., YENİCE, N., YILMAZ, Şerif, … Bağcı, S. (2012). Safety of peginterferon alfa-2a (40KD) treatment in patients with chronic hepatitis B infection: An observational, multicenter, open label, non-interventional study in Turkish patients. Turkish Journal of Gastroenterology, 23(5), 552–559. https://doi.org/10.4318/tjg.2012.0410

Nurdan TÖZÜN

164,

Orhan Sezgin

455,

Murat GÜLŞEN

456,

Sabite KACAR

457,

Necati YENİCE

458,

Şerif YILMAZ

459,

Saadettin HÜLAGÜ

405,

Bülent KANTARÇEKEN

460,

Fahri YAKARYILMAZ

461,

Alper YURCİ

462,

Kemal Mustafa SEREZ

463,

Halil BAHÇECİOĞLU

464,

Sait Bağcı

465,